---
title: "VERAXA Biotech AG (VRXA.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VRXA.US.md"
symbol: "VRXA.US"
name: "VERAXA Biotech AG"
industry: "Life Sciences Tools and Services"
datetime: "2026-06-13T21:00:37.500Z"
locales:
  - [en](https://longbridge.com/en/quote/VRXA.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VRXA.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VRXA.US.md)
---

# VERAXA Biotech AG (VRXA.US)

## Company Overview

VERAXA Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation. The company utilizes proprietary payloads and genetic code expansion technology to engineer and manufacture homogeneous, stable bioconjugates with defined drug-to-antibody ratios.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | US Market |
| Website | [www.veraxa.com](https://www.veraxa.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/VRXA.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/VRXA.US/norm.md)
- [Related News](https://longbridge.com/en/quote/VRXA.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/VRXA.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**